[1] |
GENG Ying, LIU Yi, WANG Xuelei, ZHU Rongdie, JIN Ying, CHEN Hua, ZHENG Li'e.
Comformity study of formulation and manufacture process for bromohexine hydrochloride parenteral preparations using Near-infrared and Raman spectroscopy
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 300-306.
|
[2] |
LI Yanyi, WEN Hairuo, YANG Yanrong, MA Shuangcheng, WANG Qi.
Identification of Hepatotoxic Components of Polygoni Multiflori Radix Based on Material Basis Combined with Heparg Cell Experiments
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(12): 1377-1381.
|
[3] |
LIU Jingjing, DAI Zhong, YANG Jianbo, WANG Ying, XU Beilei, LIU Yue, WANG Qi, MA Shuangcheng.
Spectrum-fect relationship of Ginseng Radix et Rhizoma Rubra and Polygonum Multiflorum Radix Preparata medicinal pair in protection of nerve cells
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 623-628.
|
[4] |
ZHANG Zhiqi, GUO Mingxing, XU Ye, ZHANG Jian, LIN Jun, CUI Xiangli.
One case of tacrolimus-caused reversible posterior leukoencephalopathy syndrome after renal transplantation in children
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 465-468.
|
[5] |
GENG Ying, LIU Yi, WANG Xuelei, TAN Dejiang, ZHU Rongdie, GUO Xianhui, CHEN Hua, ZHENG Li’e.
Near-infrared spectroscopic and statistical process control methods for the quantitative control of the moisture content of calcium folinate drug reference substance
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1221-1227.
|
[6] |
ZHANG Luxin, MENG Lu, ZHANG Hong.
Analysis of 327 reports of new adverse drug reactions
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1159-1162.
|
[7] |
ZUO Tiantian, WANG Zhao, GUO Yuansheng, WEI Feng, JIN Hongyu, MA Shuangcheng.
Non-carcinogenic and carcinogenic risk assessment of toxic elements in Panax quinquefolium L. based on multi-element semi-quantitative screening
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1108-1112.
|
[8] |
LI Yuanyuan, LIU Shengwei, REN Zhongyang, DING Ling, LIU Jie, LIAO Yuan.
Potential mechanism of Ginkgo biloba in the treatment of Alzheimer's disease based on network pharmacology
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 967-972.
|
[9] |
CHEN Jia, NIE Lixing, HU Xiaoru, LIU Wei, WEI Feng, MA Shuangcheng.
Differences of chemical compounds between Glycyrrhiza uralensis Fisch. and Glycyrrhiza glabra L. by UHPLC-Q-TOF-MS/MS
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 954-958.
|
[10] |
ZHANG Qiang, DU Pengcheng, MAN Chunrui, SUN Qian.
Network pharmacology of protection against angina pectoris by Ginkgo Biloba
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(2): 158-163.
|
[11] |
YU Yi, HUANG Qianqian, XIAO Aili.
Analysis of Safety Risks of Ginkgo Biloba Tablets and Other Oral Preparations
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 678-682.
|
[12] |
ZHAO Yu-xin, GAO Hui-qin, ZHANG Hao-jun, LI Xiang-ming, WANG Wen-peng, SUN Sheng-bin, JIANG Guo-zhi, LI Zhen-jiang.
Study on Refining Process Optimization of Shuxuening Injection
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(9): 542-546.
|
[13] |
YANG Le DU Xiao-xi GUO Xiao-xing REN Jing-tian SHEN Lu SONG Hai-bo* .
Literature Analysis of Extract of Adverse Drug Reaction Induced by GinkGgo Biloba Leaves Injection
[J]. Chinese Journal of Pharmacovigilance, 2014, 11(3): 163-169.
|
[14] |
ZHANG Lin-tao, ZHANG Feng, WANG Zhi-xiang, WU Xian-kun, CAI Jin-yuan.
Optimization of the Extraction Process of the Flavonoid from Ginkgo Biloba Leaves
[J]. Chinese Journal of Pharmacovigilance, 2011, 8(3): 147-150.
|